Mesenchymal Stem Cell Therapy for Osteoarthritis from United States
Mesenchymal stem cell therapy uses allogeneic MSCs derived from umbilical cord tissue, expanded and cryopreserved for intra-articular injection to treat knee osteoarthritis. These cell cultures are classified as cell therapy products under tariff item 3002.51.00.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the product is accompanied by a Health Canada-approved clinical trial application or a medical device license if applicable
• Document the cell source, expansion methods, and cryopreservation media to support classification
• Be prepared to provide additional information to the CBSA regarding the product's intended medical use